Equities

SMAIO SA

SMAIO SA

Actions
  • Price (EUR)2.50
  • Today's Change-0.21 / -7.75%
  • Shares traded1.85k
  • 1 Year change+5.04%
  • Beta--
Data delayed at least 15 minutes, as of Nov 15 2024 15:22 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

SMAIO SA is a France-based company that specializes in the design, manufacture and marketing of implantable medical devices for the treatment of spinal pathologies. The Company provides control on a surgical procedure to spine physician through a wide range of solutions like surgical plan/ i-plan, surgical procedure i-perform, outcome data/ i-check, and education/ i-learn. It operates with the clinical data and imaging for specialists in spine surgery for transformation of the vertebral fusion. It also offers spine surgeons a complete solution, consisting of software, implantable devices, associated services, and treat spinal pathologies requiring surgery. It includes Kheiron Spinal Fixation System, a device that incorporates many implants, intended for the immobilization and stabilization of spinal segments as an adjunct to fusion of the thoracic, lumbar and/or sacral spine. It also develops the Keops and Balance Analyzer 3D surgical planning and patient database management software.

  • Revenue in EUR (TTM)4.91m
  • Net income in EUR-1.79m
  • Incorporated2009
  • Employees43.00
  • Location
    SMAIO SA2 Place Berthe MorisotParc TechnologiqueSAINT-PRIEST 69800FranceFRA
  • Phone+33 469842302
  • Fax+33 428292118
  • Websitehttps://smaio.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Valerio Therapeutics SA1.89m-19.66m12.35m38.00--3.06--6.54-0.1233-0.12330.01190.02610.0515--0.512199,421.05-53.59-34.19-76.22-40.5974.7584.11-1,040.66-586.99---188.640.7662--24.74-21.73-4.00--32.39--
SMAIO SA4.91m-1.79m14.17m43.00--1.76--2.88-0.3383-0.33830.9291.540.37380.38169.41132,756.80-13.65-7.87-15.68-18.4388.4596.04-36.52-22.484.25--0.236--212.18114.99-62.80------
NicOx SA-100.00bn-100.00bn15.74m5.00--0.7203----------0.3166-----------22.59---24.55-------337.85----0.5424--26.5911.3833.26------
Advicenne SA3.02m-8.83m26.00m20.00------8.61-0.7538-0.75380.2608-1.420.32343.851.87150,950.00-94.59-57.86---89.10-116.10-327.56-292.51-513.560.2611-22.23156.51--25.6725.0338.70--55.28--
Aelis Farma SA7.55m-7.03m41.12m26.00--4.00--5.44-0.5319-0.53190.57170.750.2779--1.56290,461.50-25.85-24.53-40.55-40.55-----93.03-109.622.97--0.277--137.70--64.46--37.35--
AB Science SA1.08m-6.04m51.53m45.00------47.62-0.1204-0.12040.0213-0.46970.03850.64656.9820,415.09-21.51-65.95-70.06-515.1776.2588.41-558.50-1,148.980.798-9.11----1.25-10.6311.97---6.55--
Groupe Berkem SA52.43m-1.42m54.37m200.00----15.991.04-0.0799-0.07992.95--------262,130.00--------56.41---2.71----0.1565----0.733--123.42------
DBV Technologies SA13.12m-83.97m60.02m106.00--0.7963--4.58-0.8733-0.87330.13650.7810.0833--0.7321126,141.70-53.33-53.18-65.29-65.47--93.62-640.08-1,145.92----0.083--224.69-1.7124.27---34.47--
Data as of Nov 15 2024. Currency figures normalised to SMAIO SA's reporting currency: Euro EUR

Institutional shareholders

2.82%Per cent of shares held by top holders
HolderShares% Held
MCA Finance SAas of 29 Dec 2023111.45k2.13%
Financi�re Arbevel SAas of 30 Dec 202235.98k0.69%
Data from 29 Dec 2023 - 30 Aug 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.